Gastro-enteropancreatic Neuroendocrine Tumor - 17 Studies Found

Recruiting : A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor
: Gastroenteropancreatic Neuroendocrine Tumor
: 2013-11-19
: Drug: Famitinib Famitinib 25 mg p.o. qd
Terminated : Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
: Gastroenteropancreatic Neuroendocrine Tumors
: 2014-02-26
:
  • Drug: Gallium-68-DOTATATE PET/CT (index test)

Not yet recruiting : Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors
: Gastroenteropancreatic Neuroendocrine Tumors
: 2017-02-01
:
  • Drug: Somatuline Depot Somatul
Recruiting : Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
: Gastroenteropancreatic Neuroendocrine Tumor
: 2016-12-30
Completed : TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors
: Patients With Gastroenteropancreatic Neuroendocrine Tumors
: 2012-11-13
: Drug: 68-Ga-DOTANOC
Completed : Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours
: Gastroenteropancreatic Neuroendocrine Tumours
: 2016-05-27
Not yet recruiting : [68 Ga]-DOTANOC PET/CT in GEP-NETs
: Gastroenteropancreatic Neuroendocrine Tumors
: 2015-11-09
: Drug: [68Ga]-DOTANOC PET/CT
Recruiting : Community-based Neuroendocrine Tumor (NET) Research Study
: Gastroenteropancreatic Neuroendocrine Tumors
: 2016-04-01
Withdrawn : Pasireotide Treatment for Neuroendocrine Tumor
: Gastro-enteropancreatic Neuroendocrine Tumor
: 2016-05-16
:
  • Drug: Pasireotide Pasireotide

Recruiting : Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs
: Gastroenteropancreatic Neuroendocrine Tumors
: 2015-12-11
: Other: This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.
Next >>>